KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

Generic Information: KangQuXin (Avatrombopag) — Beijing Continent (Gyre Therapeutics), China

KangQuXin (康曲欣) carries an unusual pedigree for a Chinese generic: its marketing authorization holder is Beijing Continent Pharmaceutical Co., Ltd. — the organ-fibrosis specialist known to international investors as part of Nasdaq-listed Gyre Therapeutics — while production runs at Nanjing Haina Pharmaceutical under China's MAH separation rules. Regulators approved the product in June 2024 under 国药准字H20244130, adding a serious rare-disease developer's name to the avatrombopag supplier list. Each purple-trimmed box holds ten 20 mg film-coated tablets, one blister sheet.

What Is KangQuXin Used For?

Two adult indications follow the reference label: thrombocytopenia of chronic liver disease before elective diagnostic or surgical procedures, and chronic primary immune thrombocytopenia after inadequate response to steroids or immunoglobulin. The dual label matters in practice — a hospital pharmacy stocking one avatrombopag box can serve both the hepatology pre-procedure pathway and the hematology chronic-ITP clinic. Continent's entry into this indication reflects the company's strategy of pairing its fibrosis flagship with adjacencies where platelet and liver disease overlap, cirrhotic populations being its home turf.

How Does KangQuXin Work?

The tablet delivers avatrombopag maleate 20 mg equivalent, a small-molecule second-generation thrombopoietin receptor agonist. It binds the transmembrane region of c-Mpl on megakaryocyte precursors, amplifying platelet production additively with the body's own thrombopoietin rather than competing for the natural binding site. The pharmacologic upshot is speed and flexibility: counts move within days of the first dose, and with no metal chelation there is no fasting dance around calcium, iron or antacids — dosing survives real life.

Indications of KangQuXin (China Label)

The package insert lists both adult indications with the standard boundary note that chronic liver disease patients must not use the drug to normalize counts outside the procedure context. Gyre's public filings note the product was transferred in from a Nanjing development house before approval — a route that pairs Continent's regulatory execution with established tablet manufacturing, and one more example of how MAH separation has diversified China's generic supply of this molecule.

Dosage and Administration

Take once daily with food, swallowed whole. For the CLD bridge: dose by pre-procedure count — below 40×10⁹/L, three tablets (60 mg) daily for five days; 40 to below 50×10⁹/L, two tablets (40 mg) daily for five days — starting ten to thirteen days out, with the procedure scheduled five to eight days after the final dose. For chronic ITP: begin at one tablet daily; the physician titrates within a 40 mg daily ceiling to keep counts at or above 50×10⁹/L, reviewing blood work weekly until stable. Forgotten tablet: take it with food as soon as remembered, never double.

Side Effects of KangQuXin

Reports track the class: fever, headache, abdominal pain, nausea, fatigue and ankle swelling in CLD use; headache, fatigue, bruising, nosebleeds, gum bleeding, joint pain and respiratory infections in ITP use. Thrombosis remains the labeled serious risk — platelet monitoring is part of the therapy itself, and overshoots are handled by dose reduction or interruption. Emergency review is warranted for sudden chest pain, breathlessness or a painful swollen limb.

Storage Instructions

Keep the blister in its carton at room temperature, dry and shaded; the insert specifies storage below 25°C. No refrigeration. Out of children's reach; leftover tablets go back to a pharmacy for disposal.

Why Choose KangQuXin from GLT?

KangQuXin suits buyers who track manufacturer identity: a Nasdaq-listed parent with rare-disease credibility stands behind the MAH, while the H20244130 number gives pharmacies a clean registry check. GLT supplies sealed mainland boxes with pre-shipment photographs, runs honest side-by-side quotations against the imported original and every other generic on this page, and handles questions person-to-person on WhatsApp +86 15234153837 or [email protected] — including documentation requests from hospital pharmacies and tenders.

How to Order KangQuXin (Avatrombopag)

Message WhatsApp +86 15234153837 or write to [email protected] with your quantity and destination. A formal quotation — courier options, payment routes, lead time — returns within about a working day; confirmed orders ship sealed with complete export papers. Standing monthly schedules are available for chronic therapy.

FAQ

Why do the MAH and the factory differ? China's marketing authorization holder system separates who owns the drug registration from who runs the production line — Continent holds the approval (H20244130), Nanjing Haina manufactures under GMP contract.

Who is Beijing Continent Pharmaceutical? The Chinese operating company of Gyre Therapeutics (Nasdaq: GYRE), best known for its anti-fibrosis flagship and rare-disease development programs.

Does KangQuXin carry the ITP indication too? Yes — its label covers both adult CLD-related thrombocytopenia before procedures and chronic ITP after insufficient prior response.

Is it interchangeable with other 20 mg avatrombopag brands? Within a doctor's decision, yes — same strength and evaluated quality standard; switching brands mid-course should still go through the treating physician.

What documentation comes with a GLT shipment? Sealed original cartons, batch and expiry photographs before dispatch, CoA on request, and full export paperwork matching the destination's clearance requirements.